In addition, a transmembrane transporter, ZIP4, is significantly downregulated in prostate carcinoma and could be a sensitive biomarker for the early detection of prostate cancer, along with metallothioneins, which are zinc-binding proteins typically elevated in prostate cancer cells. Here, SLC39A4 is linked to prostate cancer.